title: Interplay between the intracellular energy sensor AMP-activated protein kinase (AMPK) and the estrogen receptor activities in regulating rat pituitary tumor cell (GH3) growth in vitro.
abstract: Estrogen receptor α has a role in regulating rat somatolactotroph tumor cell growth (GH3 cells). AMP-activated protein kinase (AMPK) is a metabolic checkpoint which is able to negatively regulate intracellular signaling downstream of growth factors receptors in conditions increasing cellular AMP levels. We have recently reported on the role of AMPK activation in affecting viability and proliferation of GH3 cells. In the present study, we investigated the interplay between ER- and AMPK-pathways. Results can be regarded as relevant to the development of novel multi-targeted pharmacological therapies against pituitary tumors. We confirmed that estradiol (E2) and the ER antagonist fulvestrant exert stimulatory and inhibitory effects, respectively on GH3 cell growth in a competitive manner. The upstream kinase LKB1 is known to phosphorylate and activate AMPK. Here we showed that neither E2 nor fulvestrant caused a downregulation of LKB1 expression and phospho-AMPK levels in GH3 cells. Actually, fulvestrant strongly reduced the phosphorylation of ACC, which is a direct target of AMPK and a known index of AMPK activity. 2-deoxyglucose, a compound reducing glucose utilization, caused an increase in AMPK activity vs baseline and was able to hinder the stimulatory effect of E2 on cell viability, confirming that the exposure of GH3 cells to estrogens does not prevent them from being responsive to the inhibitory activity of compounds activating AMPK. Finally, the AMPK activator AICAR (AMP analog) did not cause further decrease in cell viability in the course of co-treatments with fulvestrant versus fulvestrant alone, in agreement with impaired phospho-AMPK activity in the presence of the anti-estrogen.
authors: Unit of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123, Brescia, Italy, tulipano@med.unibs.it.
authors: Giovanni
authors: G
authors: Tulipano
authors: Lara
authors: L
authors: Faggi
authors: Andrea
authors: A
authors: Cacciamali
authors: Maurizio
authors: M
authors: Spinello
authors: Daniela
authors: D
authors: Cocchi
authors: Andrea
authors: A
authors: Giustina
mesh_terms: D000091162:AMP-Activated Protein Kinase Kinases; D055372:AMP-Activated Protein Kinases / Q000378:metabolism / Q000502:physiology*; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D045744:Cell Line, Tumor; D003847:Deoxyglucose / Q000494:pharmacology; D004958:Estradiol / Q000031:analogs & derivatives / Q000494:pharmacology; D065171:Estrogen Receptor Antagonists / Q000494:pharmacology; D000077267:Fulvestrant; D010911:Pituitary Neoplasms / Q000378:metabolism / Q000473:pathology*; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism / Q000502:physiology; D051381:Rats; D011960:Receptors, Estrogen / Q000378:metabolism / Q000502:physiology*
chemical_list: D000963:Antimetabolites; D065171:Estrogen Receptor Antagonists; D011960:Receptors, Estrogen; D000077267:Fulvestrant; D004958:Estradiol; D003847:Deoxyglucose; D017346:Protein Serine-Threonine Kinases; C488755:Stk11 protein, rat; D000091162:AMP-Activated Protein Kinase Kinases; D055372:AMP-Activated Protein Kinases
references: Endocrinology. 2008 Aug;149(8):4158-67
references: 18450960
references: Mol Cancer Ther. 2009 Apr;8(4):733-41
references: 19372545
references: J Physiol. 2006 Jul 1;574(Pt 1):63-71
references: 16613876
references: J Steroid Biochem Mol Biol. 1995 Dec;55(3-4):327-36
references: 8541229
references: Cell Cycle. 2010 Jan 15;9(2):211-2
references: 20023392
references: Endocrine. 2012 Oct;42(2):292-8
references: 22736409
references: PLoS One. 2010 Apr 19;5(4):e10060
references: 20419096
references: J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):439-43
references: 21689749
references: Nat Rev Mol Cell Biol. 2007 Oct;8(10):774-85
references: 17712357
references: Proc West Pharmacol Soc. 2011;54:10-4
references: 22423572
references: Pituitary. 2011 Sep;14(3):242-52
references: 21213053
references: Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20071-6
references: 23169636
references: Mol Cell Endocrinol. 2013 Jan 30;365(2):197-206
references: 23116772
references: Metabolism. 2004 May;53(5):563-70
references: 15131758
references: Circ Res. 2007 Feb 16;100(3):328-41
references: 17307971
references: J Biol. 2003;2(4):28
references: 14511394
references: J Mol Endocrinol. 2010 Feb;44(2):87-97
references: 19625456
references: Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16309-13
references: 12456889
references: Curr Biol. 2003 Nov 11;13(22):2004-8
references: 14614828